EP1333751A2 - Glucose sensor system - Google Patents

Glucose sensor system


Publication number
EP1333751A2 EP20010985206 EP01985206A EP1333751A2 EP 1333751 A2 EP1333751 A2 EP 1333751A2 EP 20010985206 EP20010985206 EP 20010985206 EP 01985206 A EP01985206 A EP 01985206A EP 1333751 A2 EP1333751 A2 EP 1333751A2
Grant status
Patent type
Prior art keywords
fluid line
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Application number
Other languages
German (de)
French (fr)
Chiun Liu Chiung
Kirk Ramey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nipro Diabetes Systems Inc
Original Assignee
Nipro Diabetes Systems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date



    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1486Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using enzyme electrodes, e.g. with immobilised oxidase
    • A61B5/14865Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using enzyme electrodes, e.g. with immobilised oxidase invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/68Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6846Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
    • A61B5/6847Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
    • A61B5/6848Needles
    • A61B5/6849Needles in combination with a needle set
    • G06F19/00Digital computing or data processing equipment or methods, specially adapted for specific applications


A sensor (10) for detection of an analyte, such as glucose, in a fluid, such as blood or other body fluid, is formed by printing components of the sensor, such as electrodes (24, 26, 28), and a sensing element (18), which contains an oxidorectase enzyme, such as glucose oxidase, on a suitable support (12). In one embodiment, the support comprises the wall (100) of a catheter (102), which is inserted into a patient's body.



Background of the Invention

The present invention relates to the sensor arts . It finds particular application in conjunction with printed electrochemical sensors of the type used, for example, in the subcutaneous or transcutaneous monitoring of blood glucose levels in a diabetic person, and will be described with particular reference thereto. It should be appreciated, however, that the invention is also applicable to the determination of other electrochemically detectable substances present in body fluids and non-body fluids.

The regulation of blood sugar levels in diabetics by careful dosage of insulin has been studied extensively. To ensure that the diabetic receives a correct dosage of insulin, it is particularly important to monitor the diabetic's glucose level. Thin film electrochemical sensors are generally known in the art for use in a variety of specialized applications, including the detection of glucose. Thick film sensors are also known. Such thin or thick film sensors may comprise one or more thin conductors applied by photolithography mask and etch techniques between thin layers of a nonconductive material, such as a polyimide film. Silk screen printing techniques have also been used in the preparation of sensors. The conductors are shaped to define distal end sensor tips having an appropriate electrode material thereon, in combination with proximal end contact pads adapted for conductive connection with appropriate electronic monitoring equipment . In recent years, thin film sensors of this type have been proposed for use as a transcutaneous sensor in medical applications. As one example, thin film sensors have been designed for monitoring blood glucose levels in a diabetic person, with the distal end sensor electrode s positioned subcutaneously in direct contact with the person's blood stream.

Such mask and etching techniques are time consuming and costly. Because body fluids tend to degrade the electrode materials and proteins tend to deposit on the electrodes, the sensors have a relatively short life. For diabetics and others who monitor glucose or other body chemicals frequently and for extended periods it is therefore desirable to have an inexpensive sensor which is disposable at intervals of a few days.

For measurement of glucose levels, sensors typically employ an oxidase enzyme, particularly glucose oxidase. The oxidase acts on a substrate or analyte, such as glucose, to produce hydrogen peroxide, and in the process, oxygen is consumed. The concentration of glucose can be determined indirectly, such as by detecting the depletion of oxygen or the generation of reaction products, such as hydrogen peroxide or gluconic acid. U.S. Patent No. 4,970,145 discloses electrodes formed from platinized carbon particles on which an enzyme, such. as glucose oxidase, is immobilized. U.S. Patent No. 5,160,416 discloses similar electrodes in which a mixture of the enzyme with finely divided platinum group metal or oxide particles and carbon powder in a suitable binder is deposited on an electrically conductive support material, such as carbon paper or a platinum strip. Both patents disclose the use of amperometric techniques to determine glucose levels.

The present invention provides a new and improved sensor and method of use which overcomes the above- referenced problems and others . Summary of the Invention

A sensor system formed by printing electrodes on a support has a variety of applications for the detection of glucose and other chemicals in vivo and in vitro. One advantage of the present invention is that a disposable sensor is readily formed.

Another advantage is that the sensor may be formed on a wall of a catheter.

Still further advantages of the present invention will become apparent to those of ordinary skill in the art upon reading and understanding the following detailed description of the preferred embodiments.

Brief Description of the Drawings

The invention may take form in various components and arrangements of components, and in various steps and arrangements of steps . The drawings are only for purposes of illustrating a preferred embodiment and are not to be construed as limiting the invention.

FIGURE 1 is a top view of a sensor according to the present invention;

FIGURE 2 is a perspective sectional view in partial section through A-A of the sensor of FIGURE 1;

FIGURE 3 is a schematic view of a combination infusion pump and glucose meter according to the present invention;

FIGURE 4 is a schematic sectional view of a sensor inserted through the wall of a catheter;

FIGURE 5 shows a sensor in use in a closed loop system; FIGURE 6 is a schematic sectional view of a subcutaneous sensor system mounted to an exterior of a catheter wall and signaling a glucose meter, according to the present invention;

FIGURE 7 is a schematic sectional view of a subcutaneous sensor mounted to an interior of a catheter wall and signaling a glucose meter coupled to an insulin pump;

FIGURE 8 is a top view of a sheet of support material with sensors printed thereon; FIGURE 9 is a side perspective view of the support sheet of FIGURE 8 rolled into a catheter shape with the sensors on the exterior; and

FIGURE 10 is a side sectional view of an infusion set with a catheter passing through a person's skin.

Detailed Description of the Preferred Embodiments

With reference to FIGURES 1 and 2, a sensor 10 is shown. While the sensor is described with reference to glucose detection, it will be appreciated that the sensor may also be used for detection of other electrochemically detectable chemicals . ;

The sensor comprises a support 12, formed from an insulative material, such as a sheet of polyester, polycarbonate, or polyimide. The support defines a well 14 adjacent one end of its upper surface 16. A sensing material 18 is deposited at the base and on the sides of the well. The sensing material 18 includes an oxidoreductase enzyme, such as glucose oxidase, with is capable of catalyzing the reaction of a substrate or analyte (e.g., glucose) . In the case of glucose, the glucose oxidase enzyme acts on the glucose to produce hydrogen peroxide, the reaction consuming oxygen. Other suitable oxidoreductases include uricase, lactase oxidase, cholesterol oxidase, and other peroxide-producing enzymes. Combinations of enzymes may also be used, as well as combinations of non-oxidases and oxidases, the non-oxidase acting on a substrate of interest to produce an oxidizable substrate for the oxidase . One such combination is beta-galactosidase and glucose oxidase for the determination of lactose.

The sensing material 18 preferably also includes a platinum group metal or metal oxide in finely divided form, which is relatively homogeneously mixed with the oxidase. Suitable platinum group metals and oxides thereof include platinum, ruthenium, rhodium, iridium, palladium., and their oxides, and combinations thereof. Ruthenium is a particularly preferred metal. The sensing material may further include a carbon-containing material, such as finely divided carbon or graphite powder. Such materials preferably have a relatively large surface area of about 10 m3/gm or higher, most preferably, in the range of 200-600 m3/g. Preferably, the platinum group metal or metal oxide has a particle size in the range of from about 1 nm to about 20 μ , most preferably, in the range of 1-4 μm.

A droplet or layer of an analyte-containing liquid or viscous fluid 20 to be analyzed for the substrate is added to the well . An electrode system 22 detects a product generated (e.g., hydrogen peroxide or gluconic acid) or a chemical consumed (e.g., oxygen) . Hydrogen peroxide is a particularly preferred detectable substance. A variety of electrode' systems may be employed for detection. FIGURES 1 and 2 show a 3-electrode system, with a working electrode 24, reference electrode 26, and a counter electrode 28, laid down generally in parallel on the support surface so that at least a portion of each of the electrodes is in contact with the fluid 20. However, other electrode systems may also be employed, such as a two electrode system employing working and reference electrodes.

The electrode system is in electrical contact with the analyte 20. As shown in FIGURE 1, the electrodes take the form of strips, laid down on the support, with contact pads 30 at a proximal end of the support for electrically connecting the electrodes with electrochemical equipment (not shown) . A variety of electrochemical measurement techniques may be employed with the electrode system, including amperometric and potentiometric techniques. For example, a voltage is periodically applied between the working and reference electrodes 24, 26 and the current generated due to reduction of hydrogen peroxide measured between the working and counter electrodes . The electrode system generates an electrical signal

(current in the above embodiment) which is related to

(directly proportional to, in the case of glucose and hydrogen peroxide) the concentration of the analyte substance to be detected (e.g., glucose). Using a look-up table, the electrochemical monitoring system compares the detected signal with calibrated concentration/signal data and produces an output indicative of the concentration of glucose or other substance present . Various conductive materials may be used for forming the electrodes. In a preferred embodiment, the working electrode is formed from nickel or silver, the counter electrode is carbon, and the reference electrode is an Ag/AgCl electrode. Other materials or combinations of materials may also be used as is known in the art.

The electrodes may be formed by a variety of techniques, including lithography, printing, and the like. The electrode materials, e.g., ruthenium and glucose oxidase for the sensing material 18, are mixed together and combined with a carrier liquid to form a suspension which is deposited on the support. In a preferred embodiment, the electrodes 24, 26, 28, and also the sensing material 18 and contact pads 30 are printed on the support material, for example by inkjet, offset, laser, silk-screen, or gravure printing techniques. Both thin and thick film printing techniques may be used.

Inks are prepared by combining the materials for the electrodes or sensing material with a suitable carrier, such as a liquid or a material which flows at the temperature of printing. The inks are then printed on the support and dried or otherwise fixed. The inks can be laid down in a multi-step process, by printing a first material, which is allowed to dry, followed by a second material, and so forth, until all the materials are laid down. In the case of the sensing material, the enzyme, metal or metal oxide, and carbon powder may be mixed together with a carrier liquid to form an ink which is printed on the support. Or, the enzyme, metal or metal oxide, and carbon powder may be separately laid down, each one in a separate ink formulation.

For example, a thick film process can be used to produce the sensor. In this process, a silk screen printing process is preferably used. The design of the sensor elements is first transferred onto a screen (which can be a metal mesh or polymer screen) by a photographic method. The selected metal or conductive electrode materials can be prepared or purchased commercially in ink or paste form. Placing the substrate, such as a polyimide or other film, in a thick film printing printer with the patterned screening over the polyimide film, the ink or paste can be applied onto the polyimide surface through the patterned screen using a controlled squeegee. The ink can then be dried by heat or UN curing.

The carrier liquid may be an aqueous or organic liquid or combination thereof and is preferably one which is readily removed from the electrode material or sensing material after printing, e.g., by evaporation, although leave-in carriers are also contemplated. In the case of the sensing material, the enzyme is generally sensitive to heat. The ink is therefore dried or otherwise fixed at a temperature which does not adversely affect the activity of the enzyme.

Preferably, multiple sensors are printed at one time by forming an array of sensors on a large sheet of the support material . The sheet is then cut to form the individual sensors . In one embodiment, the sensor 10 is used outside the body to determine the glucose level in a droplet of blood or other body fluid. The droplet is withdrawn from the body and placed in the well. To aid in positioning the droplet in the well, a layer 34 of a wicking material is attached to the support surface 16 over the general area of the well . The droplet is applied to the wicking material and carried thereby into the well. To measure the glucose concentration, the sensor is electrically connected with an electrochemical monitoring system, such as a glucose meter 40 (See FIGURE 3) . The glucose meter both supplies the applied voltage (or current) and detects the current (or voltage) signal generated. It will be appreciated that the two functions of applying voltage/current and detecting the signal generated may be performed by separate components, although for convenience these are shown as a single unit, the glucose meter. FIGURE 3 shows the glucose meter in a housing 42, which also holds an infusion pump 44, although separate glucose meters are also contemplated. After applying the droplet, the sensor 10 is inserted into a suitably shaped slot 46 in the housing, the slot having electrical connectors (not shown) which electrically connect the contact pads 30 with the glucose meter. The glucose meter determines the glucose concentration and signals a controller 50 (which may be integral with or separate from the glucose meter) . The controller 50 calculates an appropriate response to the detected level by accessing look-up tables. In one embodiment, the controller may recommend that a dose of a medicament (e.g., a number of ml of insulin) be supplied to the person (e.g., from the infusion pump) . Or, the controller may recommend that the person ingest carbohydrate. The recommended dose or other action step to be taken is displayed in human readable form, such as on a display screen 54. The person may accept the recommended dose, for example by pressing keys on a keypad 56, or may enter a different dose to be taken. The controller then instructs the infusion pump 44 to deliver to the selected dose, for example, by operating a motor 58 to drive a piston 60 of a syringe 66 containing the medicament . The medicament, e.g., insulin, is carried by suitable tubing 68 from the syringe into the person's body. In an alternate embodiment, the controller may override the person in selecting a suitable dose, so that the person is not injected with a dangerous level of the medicament. In yet another embodiment, the personal input 56 is eliminated and the controller instructs the insulin pump directly.

In another embodiment, the sensor 10 is used to detect glucose or other body chemical a body fluid flowing through tubing, such as a catheter 70 (see FIGURE 4) . For this embodiment, the support 12 is formed from a material (e.g., polyimide or polyurethane) and/or is shaped (e.g., with a rounded end 72 or pointed tip) so that it is capable of piercing the catheter wall 74. In this embodiment, the sensor support 12 is preferably formed from a rigid material and of a sufficient thickness that does not readily break during piercing. Catheters, in general, are formed from a relatively soft material, which is capable of being pierced. The electrode system 22 is thereby positioned to be immersed in the body fluid or other liquid to be analyzed in the bore 76 of the catheter. In this embodiment, the well 14 and wicking membrane 34 may be eliminated as the electrodes 24,26,28 and sensor material 18 are in direct contact with the analyte. The wicking membrane may be replaced with a protein-impermeable membrane or coating 80 or other membrane which inhibits the passage of materials which may be detrimental to the operation of the sensor. The membrane covers those portions of the sensor which are affected by the detrimental materials, such as the electrodes and/or the sensing material. The membrane 80 is, however, permeable to at least glucose (or other chemical to be detected) .

Suitable protein impermeable membranes may be formed from a mixture of 2-hydroxyethyl methacrylate (HE A) , N,N-dimethyl amino ethyl methacrylate (DMAEMA) and ethacrylic acid (MA) , although other protein-impermeable materials are also contemplated. Alternatively or additionally, a coating which resists blood coagulation and protein binding may also be used, such as a mixture of polyethylene glycol (PEG) and heparin.

With reference to FIGURE 5, the sensor of FIGURE 4 may be employed in a loop system, such as a dialysis system (see FIGURE 5) . The loop system has one fluid path defined by a first catheter 84 which carries body fluid, such as blood, from a patient's body 86 to a dialysis machine 88 or other suitable monitoring or treatment equipment. A second, return catheter 90, returns the treated body fluid back to the patient. The sensor 10 is inserted into one of the catheters 84, 90 (FIGURE 5 shows the sensor in the input line 84) , to detect the glucose content of the fluid flowing therethrough. The sensor may be operated continuously or intermittently, every few minutes, or as appropriate, to monitor the changing glucose level. The sensor is electrically connected by wiring 92 (or radio telemetry) to a glucose meter 94, which may be housed with the dialysis machine. As before, the glucose meter uses electrochemical techniques to monitor glucose levels, for example, by directing the hydrogen peroxide generated by enzymatic conversion of the glucose in a small region of the body fluid adjacent the sensing element 18. When the glucose meter registers that the glucose level is within a predetermined range, the glucose meter instructs the dialysis machine 88 to cease purifying the blood or to take other appropriate action. Alternatively, this operation may be conducted by a trained operator, who reads the glucose level detected by the glucose meter and programs the dialysis machine accordingly.

In another embodiment, shown in FIGURE 6, the sensor is employed for subcutaneous monitoring of glucose concentrations. The sensor 10 is mounted to a wall 100 of a catheter tube 102 such as a cannula, which may be employed to deliver insulin, or other medicament, to the persons blood or subcutaneous fluid. An infusion set 104 connected with a suitable insulin pump similar to that illustrated in FIGURE 3, or other delivery apparatus, delivers insulin to the catheter, which carries the insulin through the skin 106 and into a blood vessel, e.g., an artery, or into the interstitial fluid. The sensor may be positioned on an exterior surface 108 of the canula wall 100, as shown in FIGURE 6, or on an interior surface 110 of the wall, as shown in FIGURE 7. The sensor 10 generates an electrical signal in response to an applied voltage or current which is related to the glucose level in the blood vessel or interstitial fluid adjacent the sensor. Electrical wiring 112 (or radio telemetry) connects the sensor 10 with a glucose meter 114. As previously described, the glucose meter may be a separate unit (FIGURE 6) or housed together with an insulin pump 44 and controller 50 (see FIGURE 7) , analogous to that shown in FIGURE 3.

When formed on the inside of the wall (FIGURE 7) , the sensor 10 is used between dosages of insulin, when the catheter is filled primarily with interstitial fluid or blood and the fluid line 68 to the insulin pump 44 is preferably closed off .

The wiring 112 may be attached to the exterior 108 of the catheter wall 100 (FIGURE 6) , attached to the interior surface 110, or integrally formed with the catheter wall 100 so that it is encased by the catheter wall (FIGURE 7) .

In a preferred embodiment, illustrated in FIGURES 8 and 9, the electrodes 24, 26, 28 and sensing material 18 of the sensor 10, and optionally also a portion of the wiring 112 are applied directly to a surface 108, 110 of the catheter wall 100. The catheter wall 100 thus provides the support 12 for the sensor. The sensor may be formed, as shown in FIGURES 6 and 7, on an exterior or interior wall of the catheter, either by printing a preformed catheter or by forming the sensor components on a sheet 120 which is then rolled into the shape of the catheter and joined at a seam 122, either by welding or with a suitable adhesive.

The application of the sensor components 18, 24, 26, 28,30 is preferably achieved by printing the components on the sheet 120 or formed catheter, although other application methods are also contemplated. As shown in FIGURES 8 and 9, a number (two are shown) of sensors 10, 10' may be printed on a single catheter. As for the embodiment of FIGURE 4, a protein impermeable membrane 80 is preferably formed over the sensor.

With reference now to FIGURE 10, the wiring 112 may be carried by the catheter 102 to a cannula housing 130 of the infusion set 104. The infusion set comprises the cannula housing, which holds the upstream end of the catheter 102, and an injection hub 132, which carries a needle 136. The injection hub is selectively linked to the cannula housing to supply insulin to the catheter via the needle 136. The needle is fluidly connected with the fluid line 68 and carries the medicament through a septum 138, mounted at the upstream end of the catheter, into the catheter bore.

The wiring 112 is connected to the glucose meter via a connection made when the hub 132 and cannula housing 130 are linked. Additional wiring 140 may be attached to the fluid line 68, in a similar manner to wiring 112, to electrically connect the wiring 112 with the glucose meter 114, or radio telemetry may be used to transfer the signal thereto.

To use the sensor in vivo (i.e., transcutaneously) , the cannula 102 with the sensor 10 formed thereon is inserted into the person's body with an insertion needle (not shown) , for example, by replacing the injection hub 132 of the infusion set 104 with an insertion hub having a needle which extends through the cannula to just beyond the distal end of the cannula. The needle is inserted through the skin, carrying the cannula with it.

Once the cannula has been inserted, the insertion needle is withdrawn and the insertion hub replaced with the injection hub. The sensor is then ready for use. The sensor may be used continuously or intermittently to provide glucose measurements over a period of hours or several days . Typically, diabetics change the site of insulin injection every few days to prevent damage to the skin. With each change of site a fresh catheter is inserted into the skin, accompanied by a fresh sensor 10 or sensors. The sensor is preferably configured (for example, with a protein- impermeable membrane) so that the signal does not degrade appreciably within the period of use, preferably functioning effectively for several days, or more. As will be readily appreciated, the catheter with the sensor 10 printed thereon need not be used with an infusion set 104 as shown in FIGURES 6 and 7, but may be used with other methods of drug delivery, or may be used with a blood treatment system, such as the dialysis unit of FIGURE 5.

With reference once more to FIGURES 1 and 2, the sensor 10 may also include a heating element 150, such as a resistance heater, which is .formed on the support 12 in a similar manner to the other components (such as by printing) . The element may be formed from platinum or other suitable metal. Electrical current is supplied to the heating element 150 via leads 152, 154, which are also printed on the support 12. The heater is used to maintain the analyte at an appropriate temperature for measuring glucose concentration (i.e., by changes in H202 or 02 concentration) . Since the rate of the enzyme catalyzed reaction between glucose and oxygen is dependent on the temperature of the analyte fluid, it is preferable for the sensor to operate at a predetermined selected temperature . In this way, the glucose meter does not have to access a calibration table which corrects for fluctuations in temperature. The heater can also be used as a temperature detector, detecting the temperature of the adjacent fluid by measuring the voltage across the resistance heater at a determined applied current. As will be appreciated, the heater may be formed on an opposite surface of the support to that carrying the electrodes 24,26,28 and sensing element 18 (except where the catheter is used as the sensor support) . The sensor may also be configured to measure other properties of the analyte solution, such as pH. FIGURE 1 shows a pH detector 160 formed on the surface 16 of the support 12 (e.g., by printing). Additionally or alternatively, the sensor may be adapted to measure ketones, which can build up to dangerous levels, particularly in the blood of diabetics. While the sensor is particularly applicable to detecting glucose in blood and other body fluids of humans, it may also be used in other animals and for detection of glucose and other analytes in non-body fluids .

The invention has been described with reference to the preferred embodiment. Obviously, modifications and alterations will occur to others upon reading and understanding the preceding detailed description. It is intended that the invention be construed as including all such modifications and alterations insofar as they come within the scope of the appended claims or the equivalents thereof .


Having thus described the preferred embodiment, the invention is now claimed to be:
1. A method of detecting an analyte in solution, the method including: providing a sensor (10) for detecting the analyte on a fluid line (102) ; inserting the fluid line in a person's body; detecting a concentration of the analyte in body fluid surrounding the fluid line.
2. The method of claim 1, wherein the analyte includes glucose.
3. The method of claim 1, further including: communicating the sensed analyte to an analyte delivery system; and delivering a medicament to the person through the fluid line in accordance with the concentration of the sensed analyte .
4. The method of claim 3 , wherein the analyte includes glucose and the medicament includes insulin.
5. The method of claim 1, wherein the sensor includes electrodes and/or other sensing elements (24, 26, 28, 18) which are printed on to a surface of the fluid line.
6. The method of claim 5, wherein the step of printing includes printing a sheet of material with a plurality of electrodes and/or other sensing elements; sectioning the sheet into strips, each strip having a set of electrodes and/or other sensing elements for the sensor; and forming each of the strips into a fluid line.
7. The method of claim 6, wherein each of the strips is printed with electrodes or other sensing elements (24, 26, 28, 18) for sensing at least two properties of the body fluid.
8. The method of claim 7, wherein the at least two properties are selected from the group consisting of glucose concentration, ketone concentration, and pH.
9. A sensor for detecting glucose or other analyte in solution the sensor including at least one electrode which is printed on an exterior surface of a fluid line, the fluid line being for delivering a medicament to a person, the sensor being capable of detecting the glucose or other analyte in the person's body fluid adjacent the fluid line when the fluid line is inserted into the person's body.
10. The sensor of claim 9, wherein the sensor includes a sensing material (18) which includes an oxidoreductase enzyme .
11. The sensor of claim 10, wherein the sensing material further includes : a platinum group metal or metal oxide in finely divided form.
12. The sensor of claim 11, wherein the platinum group metal or metal oxide is selected from the group consisting of platinum, ruthenium, rhodium, iridium, palladium, and their oxides, and combinations thereof.
• 13. A sensing and injection system comprising: a source of a medicament; a pump for delivering the medicament to a fluid line, the fluid line having an end capable of being inserted into a person's body; a sensor for an analyte positioned at or adjacent the end of the fluid line such that the sensor is capable of detecting the concentration of the analyte in the person's body fluid adjacent the end of the fluid line when inserted; and a means for receiving the detected analyte concentration and determining an amount of medicament to be supplied in response to the detected analyte concentration.
14. The system of claim 13, further including: a means for controlling the pump to deliver the determined amount of medicament .
EP20010985206 2000-11-13 2001-11-13 Glucose sensor system Withdrawn EP1333751A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US24811800 true 2000-11-13 2000-11-13
US248118P 2000-11-13
PCT/US2001/051213 WO2002039086A9 (en) 2000-11-13 2001-11-13 Glucose sensor system

Publications (1)

Publication Number Publication Date
EP1333751A2 true true EP1333751A2 (en) 2003-08-13



Family Applications (1)

Application Number Title Priority Date Filing Date
EP20010985206 Withdrawn EP1333751A2 (en) 2000-11-13 2001-11-13 Glucose sensor system

Country Status (3)

Country Link
EP (1) EP1333751A2 (en)
JP (1) JP2004512914A (en)
WO (1) WO2002039086A9 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1620004A2 (en) * 2003-04-15 2006-02-01 Optiscan Biomedical Corporation Dual measurement analyte detection system
US8626257B2 (en) 2003-08-01 2014-01-07 Dexcom, Inc. Analyte sensor
US20050033263A1 (en) * 2003-08-07 2005-02-10 Medtronic-Minimed, Inc. System and method for restenosis mitigation
US20060263839A1 (en) * 2005-05-17 2006-11-23 Isense Corporation Combined drug delivery and analyte sensor apparatus
US7768408B2 (en) 2005-05-17 2010-08-03 Abbott Diabetes Care Inc. Method and system for providing data management in data monitoring system
EP2260759B1 (en) 2005-06-17 2015-05-06 F. Hoffmann-La Roche AG Sensor system, arrangement and method for monitoring a compound, in particular glucose in body tissue.
US8880138B2 (en) 2005-09-30 2014-11-04 Abbott Diabetes Care Inc. Device for channeling fluid and methods of use
US7826879B2 (en) 2006-02-28 2010-11-02 Abbott Diabetes Care Inc. Analyte sensors and methods of use
US9119582B2 (en) 2006-06-30 2015-09-01 Abbott Diabetes Care, Inc. Integrated analyte sensor and infusion device and methods therefor
US8932216B2 (en) 2006-08-07 2015-01-13 Abbott Diabetes Care Inc. Method and system for providing data management in integrated analyte monitoring and infusion system
US8532730B2 (en) * 2006-10-04 2013-09-10 Dexcom, Inc. Analyte sensor
US8579853B2 (en) 2006-10-31 2013-11-12 Abbott Diabetes Care Inc. Infusion devices and methods
WO2008078319A1 (en) * 2006-12-22 2008-07-03 Medingo Ltd. Fluid delivery with in vivo electrochemical analyte sensing
US9636450B2 (en) 2007-02-19 2017-05-02 Udo Hoss Pump system modular components for delivering medication and analyte sensing at seperate insertion sites
WO2009060432A1 (en) * 2007-11-07 2009-05-14 Medingo Ltd. Device and method for preventing diabetic complications
CN101978258A (en) * 2008-01-18 2011-02-16 生命扫描苏格兰有限公司 Test strips, methods, and system of manufacturing test strip lots having a predetermined calibration characteristic
JP2010005359A (en) * 2008-04-02 2010-01-14 Takao Usui Puncture device
WO2010009172A1 (en) 2008-07-14 2010-01-21 Abbott Diabetes Care Inc. Closed loop control system interface and methods
JP4859003B2 (en) * 2009-02-18 2012-01-18 学校法人同志社 Electrochemical method for the determination of hydrogen peroxide
US20120029332A1 (en) * 2009-03-16 2012-02-02 Arkray, Inc Method of Continuously Measuring Substrate Concentration
CN104799866A (en) 2009-07-23 2015-07-29 雅培糖尿病护理公司 The analyte monitoring device
US20110082356A1 (en) * 2009-10-01 2011-04-07 Medtronic Minimed, Inc. Analyte sensor apparatuses having interference rejection membranes and methods for making and using them
JP2014517723A (en) * 2011-04-05 2014-07-24 ファルマセンス アクチェンゲゼルシャフト Venous access for transdermal mounting device
CN104245042B (en) * 2012-04-23 2018-03-06 西门子医疗保健诊断公司 The sensor array
GB2505694B (en) * 2012-09-07 2017-03-22 Lifescan Scotland Ltd Electrochemical-based analytical test strip with bare interferent electrodes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4403984A (en) * 1979-12-28 1983-09-13 Biotek, Inc. System for demand-based adminstration of insulin
US5497772A (en) * 1993-11-19 1996-03-12 Alfred E. Mann Foundation For Scientific Research Glucose monitoring system

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
See references of WO0239086A2 *

Also Published As

Publication number Publication date Type
WO2002039086A8 (en) 2003-05-30 application
WO2002039086A2 (en) 2002-05-16 application
JP2004512914A (en) 2004-04-30 application
WO2002039086A3 (en) 2003-04-03 application
WO2002039086A9 (en) 2003-06-26 application

Similar Documents

Publication Publication Date Title
Johnson et al. In vivo evaluation of an electroenzymatic glucose sensor implanted in subcutaneous tissue
Alcock et al. Continuous analyte monitoring to aid clinical practice
US6014577A (en) Device for the detection of analyte and administration of a therapeutic substance
US8216138B1 (en) Correlation of alternative site blood and interstitial fluid glucose concentrations to venous glucose concentration
US4671288A (en) Electrochemical cell sensor for continuous short-term use in tissues and blood
US6438414B1 (en) Collection assemblies, laminates, and autosensor assemblies for use in transdermal sampling systems
US6999810B2 (en) Biosensor and methods of use thereof
US20050249606A1 (en) Devices and methods for use in assessing a flow condition of a fluid
US20040249253A1 (en) Devices, systems and methods for extracting bodily fluid and monitoring an analyte therein
US20100331644A1 (en) Housing for an intravascular sensor
US20080033269A1 (en) Catheter-free implantable needle biosensor
US5694932A (en) Sensor array
Wang Glucose biosensors: 40 years of advances and challenges
US20040087671A1 (en) Compositions and methods for enhancement of transdermal analyte flux
US20080283396A1 (en) Analyte Sensor with Insertion Monitor, and Methods
US7295867B2 (en) Signal processing for measurement of physiological analytes
EP0351891A2 (en) Printed electrodes
US6553244B2 (en) Analyte monitoring device alarm augmentation system
US20050272989A1 (en) Analyte sensors and methods for making and using them
US6398562B1 (en) Device and methods for the application of mechanical force to a gel/sensor assembly
US6059736A (en) Sensor controlled analysis and therapeutic delivery system
US5387327A (en) Implantable non-enzymatic electrochemical glucose sensor
US7120483B2 (en) Methods for analyte sensing and measurement
US7299082B2 (en) Method of calibrating an analyte-measurement device, and associated methods, devices and systems
US6391643B1 (en) Kit and method for quality control testing of an iontophoretic sampling system

Legal Events

Date Code Title Description
AK Designated contracting states:


AX Request for extension of the european patent to

Countries concerned: ALLTLVMKROSI

17P Request for examination filed

Effective date: 20020712

17Q First examination report

Effective date: 20030722

RTI1 Title (correction)


RTI1 Title (correction)


RTI1 Title (correction)


18D Deemed to be withdrawn

Effective date: 20040602